ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 180 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,849,000 | -0.9% | 31,000 | +20.6% | 0.03% | +18.2% |
Q1 2022 | $1,866,000 | +5.7% | 25,700 | +22.4% | 0.02% | +22.2% |
Q4 2021 | $1,766,000 | -29.8% | 21,000 | -24.7% | 0.02% | -30.8% |
Q3 2021 | $2,516,000 | +23.3% | 27,900 | +30.4% | 0.03% | +30.0% |
Q2 2021 | $2,040,000 | -56.3% | 21,400 | -47.8% | 0.02% | -59.2% |
Q1 2021 | $4,668,000 | -17.8% | 41,000 | 0.0% | 0.05% | -24.6% |
Q4 2020 | $5,676,000 | +68.4% | 41,000 | 0.0% | 0.06% | +38.3% |
Q3 2020 | $3,370,000 | +79.5% | 41,000 | +70.8% | 0.05% | +74.1% |
Q2 2020 | $1,877,000 | +96.5% | 24,000 | +11.6% | 0.03% | +42.1% |
Q1 2020 | $955,000 | -34.0% | 21,500 | -5.7% | 0.02% | -24.0% |
Q2 2019 | $1,448,000 | -29.9% | 22,800 | -23.5% | 0.02% | -78.1% |
Q1 2019 | $2,067,000 | +114.2% | 29,800 | +34.2% | 0.11% | +81.0% |
Q4 2018 | $965,000 | -60.3% | 22,200 | -30.3% | 0.06% | -59.1% |
Q3 2018 | $2,431,000 | -19.2% | 31,850 | -18.6% | 0.15% | -40.1% |
Q2 2018 | $3,009,000 | +46.4% | 39,150 | -2.9% | 0.26% | +26.0% |
Q1 2018 | $2,055,000 | +8.3% | 40,300 | -1.5% | 0.20% | +3.0% |
Q4 2017 | $1,897,000 | -15.2% | 40,900 | -2.6% | 0.20% | -15.4% |
Q3 2017 | $2,237,000 | +38.5% | 42,000 | 0.0% | 0.23% | +22.5% |
Q2 2017 | $1,615,000 | -43.3% | 42,000 | 0.0% | 0.19% | -49.6% |
Q1 2017 | $2,847,000 | -5.8% | 42,000 | -2.3% | 0.38% | -38.8% |
Q4 2016 | $3,023,000 | -0.9% | 43,000 | 0.0% | 0.62% | +12.3% |
Q3 2016 | $3,050,000 | +122.8% | 43,000 | +53.6% | 0.55% | +113.6% |
Q2 2016 | $1,369,000 | +116.3% | 28,000 | +180.0% | 0.26% | +124.3% |
Q1 2016 | $633,000 | – | 10,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |